loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (KDMF) for Oteracil Potassium Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    Oteracil Potassium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Kyongbo Pharmaceutical Co., Ltd
    South Korea
    		 Kyungbo Pharmaceutical Co., Ltd. 459-2-ND Oteracyl potassium 2009-11-25 Kyungbo Pharmaceutical Co., Ltd. South Korea 174 Silok-ro, Asan-si, Chungcheongnam-do
    28/09/2024 Sumitomo Chemical
    Japan
    		 Jeil Pharmaceutical Co., Ltd. 21-2-ND Oteracyl potassium 2003-07-22 Sumitomo Chemicals Co., Ltd. Gifu Plant, Oita Works Japan 3750, Aza Juhachicho, Maki, Anpachicho, Anpachigun, Gifu Prefecture, 503-0125, Japan (27-1, Shinkawa 2-chome, Chuo-ku, Tokyo 104-8260, Japan)